Grothey Grapples With Treatment Options in mCRC
Axel Grothey, MD, discusses sidedness and first- and second-line treatments for patients with metastatic colorectal cancer.
Source: OncLive
Berkshire Hathaway Inc. (NYSE: BRK.A) (NYSE: BRK.B) Reports Fourth Quarter and Full Year 2020




